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Abstract
PIM3 belongs to a family of proto oncogenes that encode serine/threonine protein kinases in 
human.  Pim-3 is  involved in cell  cycle progression, suppression of  apoptosis  and proliferation of 
human hepatoma cell lines. During normal  cell cycle progression, Bcl-2 associated death promoter 
(BAD protein) inactivates Bcl-2 and Bcl-xL there by promoting apoptosis. However, phosphorylation 
of  BAD protein  by  Pim-3  leaves  Bcl-2  free  to  inhibit  Bax-triggered  apoptosis.  Thus,  designing 
inhibitors  against  Pim-3  would  stop  BAD  phosphorylation,  hence  would  be  highly  useful  for 
development of novel means of cancer therapeutics. Computer aided drug designing approach was 
followed here  to  explore  lead  molecules  targeting  human Pim-3.  For  this,  proteomic  nature  and 
phylogeny of human Pim-3 was studied. A homology model of human Pim-3 was generated based on 
crystal structure of human Pim-1 (PDB ID: 1XWS) using Modeller9v7. Pim-1 inhibitor ‘BI1’ was 
incorporated into the 3D model and further energy minimized by applying OPLS force field in Maestro 
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v9.0. The stereochemistry assessment of the model had revealed a highly reliable model with 94.8% of 
residues in the most favored region and no residues in disallowed region of Ramachandran plot. The 
human Pim-3  3D model inhibitor (BI1) complex was analyzed to locate active site residues such as 
Leu44, Gly45, Phe49, Val52, Ala65, Lys67, Glu89, Ile104, Leu120, Glu121, Arg122, Pro123, Glu171, 
Leu174, Ile185 and Asp186. These active site residues were further confirmed using SiteMap. BI1 and 
two published Pim family inhibitors (Imidazo[1,2-b]pyridazine,  SGI-1776) structural  analogs were 
searched from more than one million entries of Ligand.Info Metadatabase and an in house library of 
1171 compounds was prepared. Maestro 9.0 virtual screening protocol was used to check binding 
affinity of 1171 compounds into Pim-3 active site through sequential application of flexible Glide 
HTVS (Virtual High Throughput Screening), SP and XP method respectively. Fifteen lead molecules 
identified  in  the  present  study were  proposed  as  potential  drug  molecules  against  human Pim-3. 
Lead‘1’ was observed to have higher binding affinity towards human Pim-3 with lowest XP Gscore 
(-11.90 kcal/mol). The docking complex was observed to be highly stabilized through formation of 
hydrogen bond with Glu124 and Van der Waal interactions with active site residues. From the present 
study, it can be concluded that the generated model of human Pim-3 can be used for further studies and 
lead ‘1’ structure would be highly useful for designing novel inhibitors against hepatic cancer.
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